Document is current
Any future updates will be listed below
-
Authors
Rehnmark, Stefan
Shabo, Ivan
Randahl, Håkan
Wengström, Yvonne
Rydberg, Per
Hedayati, Elham
-
Clinical Trials BETA
Clinical trials referenced in this document:
2017-000641-44 at EU Clinical Trials RegisterDocuments that mention this clinical trial
-
Funding
Funding for this research was provided by:
Karolinska Institute
- License Information
-
More Information
Article History
Received: 21 September 2021
Accepted: 12 January 2022
First Online: 31 January 2022
Competing interests
: EH receives research funding from Roche and Pierre Fabre, all paid to Karolinska University Hospital. SR is a founder of Redhot diagnostics and has an ownership interest (including patents) in the company. PR has an ownership interest (including patents) in Redhot diagnostics. PR has an ownership interest (including patents) in Adduct Analys AB. All other authors declare that they have no conflicts of interest.
